title: Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis?
authors.forename: Agatha
authors.initials: A
authors.lastname: Labrinidis
authors.forename: Vasilios
authors.initials: V
authors.lastname: Liapis
authors.forename: Le M
authors.initials: le M
authors.lastname: Thai
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Atkins
authors.forename: Cristina
authors.initials: C
authors.lastname: Vincent
authors.forename: Shelley
authors.initials: S
authors.lastname: Hay
authors.forename: Natalie A
authors.initials: NA
authors.lastname: Sims
authors.forename: Andrew C W
authors.initials: AC
authors.lastname: Zannettino
authors.forename: David M
authors.initials: DM
authors.lastname: Findlay
authors.forename: Andreas
authors.initials: A
authors.lastname: Evdokiou
mesh_terms: D000818:Animals; D001862:Bone Resorption / Q000503:physiopathology; D002454:Cell Differentiation / Q000187:drug effects*; D006801:Humans; D010010:Osteoclasts / Q000166:cytology / Q000187:drug effects*; D011994:Recombinant Proteins / Q000494:pharmacology; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000494:pharmacology*
chemical_list: D011994:Recombinant Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand